The Guanxinshutong VPB After CHD Support Technique Has Cardiovascular Event The Easily Factor Influence

Objective:Through the clinical experimental study,the observation and the objective evaluation Mongolian medicine GuanxinshutongVPB to CHD implants the support after to have the cardiovascular event easily factor influence,explores the new method for the CHD two levels of preventionsMethods:40 example CHD and angina pectoris patient divides into two groups.The experimental group with the anti-blood platelet agglomeration treatment(Bolivia,aspirin) add gives GuanxinshutongVPB to treatment;the control group received anti-blood platelet agglomeration treatment(Bolivia,aspirin).Among the treatment,we observe the clinical and physical symptoms and do periodic check for 12 lead ECG.Urine routine,blood routine,liver and renal function test were examined respectively when pre-treatment and post-treatment.Result:1.Two groups of angina pectoris reveal the efficiency are 100%,the total effectiveness achieves 100%.two group of contrast result non-significance difference(P＞0.05).2.Two group of angina pectoris morbidity number of times,the duration,the ache degree and so on have the obvious change for the better,around the treatment own comparison have the significance difference(P＜0.001);Between two groups contrasts the non-significance difference(P＞0.05).3.Treats the latter two group of Mongolian medicine card period of five days chest stuffily,pants the symptom improvement result to have the remarkable difference(P＜0.05).4.Around two groups treat the blood rheology inspection to have the significance difference:Around the experimental group treats oneself to compare total cholesterol(TC),triglyceride(TG),low density lipoprotein(LDL-CH),the whole blood viscosity(cuts,the blood plasma viscosity lowly) and so on has the significance difference(P＜0.05);Around the control group treats own comparison,the whole blood viscosity(cuts lowly with cuts,the blood plasma viscosity high) and so on has the significance difference(P ＜0.05);Treats the latter two groups to contrast total cholesterol(TC),low density lipoprotein (LDL-CH),the blood plasma fibrinogen,the blood plasma viscosity and so on has the significance difference(P＜0.05);Experimental group these targets drop obviously,the experimental group surpasses the control group.Other target non-significance difference(P＞0.05).5..The treatment group electrocardiogram reveals the efficiency is 35%,the total effectiveness is 85%,the control group reveals the efficiency is 35%,the total effectiveness is 65%,two groups compares the non-statistics significance(P＞0.05).6.CHD to the human body routine blood test,the hepatorenal function does not have buliang the influence,in the testing has not seen responded not good.Conlusions:After the system clinical observation,Mongolian medicine GuanxinshutongVPB to implant the support after CHD to have the cardiovascular event factor to have the strong inhibitory action easily And has certain function to the CHD two levels of preventions...